Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,010 across all filing types
Latest filing 2025-11-21 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
董事会审计委员会实施细则 （2025年修订）
Governance Information Classification · 95% confidence The document is titled as the 'Implementation Rules of the Board Audit Committee' for 康芝药业股份有限公司 (Kangzhi Pharmaceutical Co., Ltd.) and is dated November 21, 2025. It details the structure, responsibilities, and procedures of the audit committee within the board of directors, including internal and external audit supervision, internal control evaluation, and compliance with relevant laws and stock exchange rules. The content focuses on governance and audit committee operational rules rather than presenting financial statements or audit results. It is a governance-related document outlining internal rules and committee functions rather than a report or announcement of financial results or audit findings. Therefore, it fits best under Governance Information (CGR).
2025-11-21 Chinese
董事会议事规则 （2025年修订）
Governance Information Classification · 100% confidence The document is titled "董事会议事规则 (2025年修订)" which translates to "Board Meeting Rules (2025 Revision)". It details the rules, structure, powers, meeting procedures, proposal submission, resolutions, and execution related to the company's board of directors. It is a governance document outlining internal rules and board practices rather than a report of financial results, announcements, or meeting materials. There is no indication of financial data, voting results, or meeting minutes. The content fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-11-21 Chinese
董事会提名委员会实施细则 （2025年修订）
Governance Information Classification · 95% confidence The document is titled as the 'Board Nomination Committee Implementation Rules (2025 Revision)' for 康芝药业股份有限公司. It details the structure, responsibilities, and procedures of the board nomination committee, including how directors and senior management are nominated and appointed. There are no financial statements, earnings data, or regulatory filings related to financial performance. The content focuses on governance practices related to board nominations and committee operations. This matches the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is 2575 characters, which is sufficient for a detailed governance report rather than a brief announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2025-11-21 Chinese
董事会审计委员会年报工作制度
Board/Management Information Classification · 95% confidence The document is titled as the "Board Audit Committee Annual Report Work System" of 康芝药业股份有限公司 (Kangzhi Pharmaceutical Co., Ltd.). It outlines the internal procedures, responsibilities, and governance related to the audit committee's role in the preparation and review of the company's annual report and financial statements. The content focuses on the audit committee's duties, coordination with auditors, internal control evaluations, and compliance with regulatory requirements. It is a governance and procedural document rather than an actual audit report or annual report. The document length is 2825 characters, which is relatively short and does not contain actual financial data or audit results. It is a policy or governance document related to audit and annual report preparation, fitting best under Board/Management Information (MANG) as it relates to board committee procedures and management oversight rather than the audit report itself (AR) or the annual report (10-K).
2025-11-21 Chinese
防范控股股东、实际控制人及其他关联方资金占用管理制度（2025年修订）
Governance Information Classification · 95% confidence The document is titled as a management system or policy document related to the prevention of fund occupation by controlling shareholders, actual controllers, and other related parties. It outlines principles, measures, responsibilities, and penalties related to fund management and prevention of misuse of company funds. There are no financial statements, audit opinions, earnings data, or regulatory announcements. The content is focused on internal governance and management rules regarding fund usage and control. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3566 characters, which is sufficient for a detailed governance policy but not a full financial report. Therefore, the classification is CGR with high confidence.
2025-11-21 Chinese
股东会网络投票实施细则
Governance Information Classification · 95% confidence The document is titled as the "Implementation Rules for Online Voting at the Shareholders' Meeting" of 康芝药业股份有限公司 (Kangzhi Pharmaceutical Co., Ltd.). It details the procedures, rules, and technical systems for shareholders to vote online during shareholder meetings. It references relevant laws and regulations governing shareholder meetings and voting mechanisms, including the Shenzhen Stock Exchange's online voting system. The content is procedural and regulatory in nature, focusing on the conduct and administration of shareholder voting rather than reporting financial results, management changes, or other corporate events. It is not a report of voting results, nor an announcement of a meeting or report publication. It is a governance-related document outlining internal rules and practices for shareholder meetings and voting. Therefore, the most appropriate classification is Governance Information (CGR). The document length (4627 characters) and detailed procedural content support this classification with high confidence.
2025-11-21 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.